Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.

Published: 01/15/2025

Kirillova A, Sethuraman M, Dong X, Kirdar A, Speyer G, Al Aaraj Y, Watson A, Schneider LK, Creager MD, Lafyatis R, Okawa S, Kim S, Chan SY.
Kirillova A, et al.
ERJ Open Res. 2025 Jan 13;11(1):00486-2024. doi: 10.1183/23120541.00486-2024. eCollection 2025 Jan.
ERJ Open Res. 2025.
PMID: 39811555
Free PMC article.